| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.00015 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.00013 | 1 |